BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

307 related articles for article (PubMed ID: 15367569)

  • 1. Case-control study of simian virus 40 and non-Hodgkin lymphoma in the United States.
    Engels EA; Viscidi RP; Galloway DA; Carter JJ; Cerhan JR; Davis S; Cozen W; Severson RK; de Sanjose S; Colt JS; Hartge P
    J Natl Cancer Inst; 2004 Sep; 96(18):1368-74. PubMed ID: 15367569
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Markers of past infection with simian virus 40 (SV40) and risk of incident non-Hodgkin lymphoma in a Maryland cohort.
    Rollison DE; Helzlsouer KJ; Halsey NA; Shah KV; Viscidi RP
    Cancer Epidemiol Biomarkers Prev; 2005 Jun; 14(6):1448-52. PubMed ID: 15941954
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Does simian virus 40 cause non-Hodgkin lymphoma? A review of the laboratory and epidemiological evidence.
    Engels EA
    Cancer Invest; 2005; 23(6):529-36. PubMed ID: 16203661
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antibody responses to simian virus 40 T antigen: a case-control study of non-Hodgkin lymphoma.
    Engels EA; Chen J; Hartge P; Cerhan JR; Davis S; Severson RK; Cozen W; Viscidi RP
    Cancer Epidemiol Biomarkers Prev; 2005 Feb; 14(2):521-4. PubMed ID: 15734981
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lymphoproliferative disorders in Costa Rica and simian virus 40.
    Meneses A; Lopez-Terrada D; Zanwar P; Killen DE; Monterroso V; Butel JS; Vilchez RA
    Haematologica; 2005 Dec; 90(12):1635-42. PubMed ID: 16330436
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Childhood exposure to simian virus 40-contaminated poliovirus vaccine and risk of AIDS-associated non-Hodgkin's lymphoma.
    Engels EA; Rodman LH; Frisch M; Goedert JJ; Biggar RJ
    Int J Cancer; 2003 Aug; 106(2):283-7. PubMed ID: 12800207
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High prevalence of SV40 infection in patients with nodal non-Hodgkin's lymphoma but not acute leukemia independent of contaminated polio vaccines in Taiwan.
    Chen PM; Yen CC; Yang MH; Poh SB; Hsiao LT; Wang WS; Lin PC; Lee MY; Teng HW; Bai LY; Chu CJ; Chao SC; Yang AH; Chiou TJ; Liu JH; Chao TC
    Cancer Invest; 2006; 24(3):223-8. PubMed ID: 16809147
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Population-based study of antibody to the human polyomaviruses BKV and JCV and the simian polyomavirus SV40.
    Knowles WA; Pipkin P; Andrews N; Vyse A; Minor P; Brown DW; Miller E
    J Med Virol; 2003 Sep; 71(1):115-23. PubMed ID: 12858417
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lack of serologic evidence for prevalent simian virus 40 infection in humans.
    Carter JJ; Madeleine MM; Wipf GC; Garcea RL; Pipkin PA; Minor PD; Galloway DA
    J Natl Cancer Inst; 2003 Oct; 95(20):1522-30. PubMed ID: 14559874
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hepatitis C virus and risk of non-Hodgkin lymphoma: a population-based case-control study among Connecticut women.
    Morton LM; Engels EA; Holford TR; Leaderer B; Zhang Y; Zahm SH; Boyle P; Zhang B; Flynn S; Tallini G; Owens PH; Zheng T
    Cancer Epidemiol Biomarkers Prev; 2004 Mar; 13(3):425-30. PubMed ID: 15006919
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lack of association of polyomavirus and herpesvirus types 6 and 7 in human lymphomas.
    Hernández-Losa J; Fedele CG; Pozo F; Tenorio A; Fernández V; Castellví J; Parada C; Ramón y Cajal S
    Cancer; 2005 Jan; 103(2):293-8. PubMed ID: 15593086
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Simian virus 40 tumor antigen expression and immunophenotypic profile of AIDS-related non-Hodgkin's lymphoma.
    Vilchez RA; Lopez-Terrada D; Middleton JR; Finch CJ; Killen DE; Zanwar P; Jorgensen JL; Butel JS
    Virology; 2005 Nov; 342(1):38-46. PubMed ID: 16122775
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Is there a role for SV40 in human cancer?
    Poulin DL; DeCaprio JA
    J Clin Oncol; 2006 Sep; 24(26):4356-65. PubMed ID: 16963733
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Simian virus 40 (SV40) and human cancer: a review of the serological data.
    Shah KV; Galloway DA; Knowles WA; Viscidi RP
    Rev Med Virol; 2004; 14(4):231-9. PubMed ID: 15248251
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunologic evidence of a strong association between non-Hodgkin lymphoma and simian virus 40.
    Tognon M; Luppi M; Corallini A; Taronna A; Barozzi P; Rotondo JC; Comar M; Casali MV; Bovenzi M; D'Agostino A; Vinante F; Rigo A; Ferrarini I; Barbanti-Brodano G; Martini F; Mazzoni E
    Cancer; 2015 Aug; 121(15):2618-26. PubMed ID: 25877010
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Detection of SV40 in colon cancer: a molecular case-control study from northeast Italy.
    Campello C; Comar M; Zanotta N; Minicozzi A; Rodella L; Poli A
    J Med Virol; 2010 Jul; 82(7):1197-200. PubMed ID: 20513084
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum antibodies to JC virus, BK virus, simian virus 40, and the risk of incident adult astrocytic brain tumors.
    Rollison DE; Helzlsouer KJ; Alberg AJ; Hoffman S; Hou J; Daniel R; Shah KV; Major EO
    Cancer Epidemiol Biomarkers Prev; 2003 May; 12(5):460-3. PubMed ID: 12750243
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prediagnostic circulating antibodies to JC and BK human polyomaviruses and risk of non-Hodgkin lymphoma.
    Rollison DE; Engels EA; Halsey NA; Shah KV; Viscidi RP; Helzlsouer KJ
    Cancer Epidemiol Biomarkers Prev; 2006 Mar; 15(3):543-50. PubMed ID: 16537714
    [TBL] [Abstract][Full Text] [Related]  

  • 19. SV40 enhances the risk of malignant mesothelioma among people exposed to asbestos: a molecular epidemiologic case-control study.
    Cristaudo A; Foddis R; Vivaldi A; Buselli R; Gattini V; Guglielmi G; Cosentino F; Ottenga F; Ciancia E; Libener R; Filiberti R; Neri M; Betta P; Tognon M; Mutti L; Puntoni R
    Cancer Res; 2005 Apr; 65(8):3049-52. PubMed ID: 15833832
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Simian virus 40 sequences in malignant lymphomas in Japan.
    Nakatsuka S; Liu A; Dong Z; Nomura S; Takakuwa T; Miyazato H; Aozasa K;
    Cancer Res; 2003 Nov; 63(22):7606-8. PubMed ID: 14633675
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.